Search results for "Prognosis."

showing 10 items of 2044 documents

Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multic…

2021

Background Magnetic resonance imaging (MRI) is the most accurate imaging technique for left ventricular ejection fraction (LVEF) quantification, but as yet the prognostic value of LVEF assessment at any time after ST-segment elevation myocardial infarction (STEMI) for subsequent major adverse cardiac event (MACE) prediction is uncertain. Purpose To explore the prognostic impact of MRI-derived LVEF at any time post-STEMI to predict subsequent MACE (cardiovascular death or re-admission for acute heart failure). Study Type Prospective. Population One thousand thirteen STEMI patients were included in a multicenter registry. Field Strength/Sequence 1.5-T. Balanced steady-state free precession (c…

medicine.medical_specialtyMagnetic Resonance SpectroscopyPopulationContrast MediaMagnetic Resonance Imaging CineGadoliniumVentricular Function Left030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionPredictive Value of TestsInternal medicineMedicineHumansRadiology Nuclear Medicine and imagingMyocardial infarctionProspective StudiesRegistriescardiovascular diseasesStage (cooking)educationriskeducation.field_of_studyEjection fractionmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Magnetic resonance imagingStroke Volumeleft ventricular ejection fractionmedicine.diseasePrognosisMagnetic Resonance ImaginghumanitiesST-segment elevation myocardial infarctionHeart failureCardiologycardiovascular systemST Elevation Myocardial InfarctionprognosisbusinessMacecirculatory and respiratory physiology
researchProduct

Long-term prognostic implications of revascularization in patients with known or suspected chronic coronary syndromes without ischemia in vasodilator…

2021

In this study, we evaluated the association between symptoms-guided revascularization occurred within three months following a negative vasodilator stress cardiovascular magnetic resonance (negative stress-CMR) and long-term adverse events in patients with known or suspected chronic coronary syndrome (CCS).We retrospectively evaluated 3517 patients in which the stress first-pass perfusion imaging revealed no ischemia. The primary endpoint was the composite of death, spontaneous myocardial infarction, heart failure (HF), or stroke. The association between symptoms-guided revascularization after a negative stress-CMR and the endpoint was assessed using the multivariable Cox proportional hazar…

medicine.medical_specialtyMagnetic Resonance SpectroscopyVasodilator Agentsmedicine.medical_treatmentMyocardial InfarctionIschemiaPerfusion scanningCoronary Artery Disease030204 cardiovascular system & hematologyRevascularization03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicinemedicineClinical endpointHumans030212 general & internal medicineMyocardial infarctionStrokeAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingSyndromeMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Stress cardiac magnetic resonance for mortality prediction and decision-making: registry of 2496 elderly patients with chronic coronary syndrome

2022

Abstract Introduction and objectives The management of elderly patients with chronic coronary syndrome (CCS) is challenging. We explored the prognostic value and usefulness for decision-making of ischemic burden determined by vasodilator stress cardiac magnetic resonance (CMR) imaging in elderly patients with known or suspected CCS. Methods The study group comprised 2496 patients older than 70 years who underwent vasodilator stress CMR for known or suspected CCS. The ischemic burden (number of segments with stress-induced perfusion deficit) was calculated following the 17-segment model. Subsequently, we retrospectively analyzed its association with all-cause mortality and the effect of CMR-…

medicine.medical_specialtyMagnetic Resonance SpectroscopyVasodilator stressVasodilator Agentsmedicine.medical_treatmentIschemiaMagnetic Resonance Imaging CineCoronary Artery DiseaseIndependent predictorRevascularizationPredictive Value of TestsRisk FactorsInternal medicinemedicineHumansIn patientRegistriesMortality predictionAgedRetrospective Studiesbusiness.industryGeneral MedicinePrognosismedicine.diseaseMagnetic Resonance ImagingCardiologyFemalebusinessCardiac magnetic resonancePerfusionRevista Española de Cardiología (English Edition)
researchProduct

Prevalence, management, and outcome of adverse rhythm disorders in takotsubo syndrome: insights from the international multicenter GEIST registry

2019

One important complication related to takotsubo syndrome (TTS) is adverse rhythm disorders. Our study was conducted to determine the incidence and management of adverse rhythm disorders in TTS and its long-term prognostic impact. We analyzed 906 TTS patients from 9 European centers. Patients were divided into the adverse rhythm disorders group (encompassing ventricular tachycardia, ventricular fibrillation, torsade de pointes, and asystole or complete atrioventricular block) and non-adverse rhythm disorders group. In our study cohort, we identified 67 (7.4%) patients with presence of adverse rhythm disorders. TTS patients were followed up over a period of 2.8 years. In the adverse rhythm di…

medicine.medical_specialtyMalignant arrhythmia030204 cardiovascular system & hematologyGlobal HealthVentricular tachycardia03 medical and health sciences0302 clinical medicineHeart RateRisk FactorsTakotsubo CardiomyopathyInternal medicinePrevalencemedicineHumansMulticenter Studies as TopicRegistries030212 general & internal medicineAsystoleOutcomebusiness.industryIncidenceICDCardiogenic shockMortality rateDisease ManagementArrhythmias CardiacVentricular tachycardiaTorsade de pointePrognosismedicine.diseaseManagementHeart failureVentricular fibrillationCohortTakotsubo syndromeCardiology and Cardiovascular MedicineComplicationbusinessHeart Failure Reviews
researchProduct

Acute hepatic failure: limitations of medical treatment and indications for liver transplantation.

1993

medicine.medical_specialtyMedical treatmentbusiness.industrymedicine.medical_treatmentLiver failureInsuficiencia hepaticaGeneral MedicineLiver transplantationPrognosisMolecular medicineGastroenterologyHuman geneticsLiver TransplantationAcute hepatic failureTransplantationInternal medicineHepatic EncephalopathyDrug DiscoverymedicineMolecular MedicineHumansbusinessGenetics (clinical)The Clinical investigator
researchProduct

Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease

2020

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. However, the indication of this drug class is still blood glucose lowering in type 2 diabetic patients with estimated glomerular filtration rate >45mL/min/1.73m2. Based on the new evidence, several scientific societies have emphasized the preferential prescription of SGLT2i for patients at risk of heart failure or kidney disease, but still within the limits set by health authorities. A r…

medicine.medical_specialtyMedicina030232 urology & nephrologyRenal functionReviewsType 2 diabetes030204 cardiovascular system & hematologyDiabetic nephropathy03 medical and health sciences0302 clinical medicineSodium-Glucose Transporter 2Internal medicineDiabetes mellitusDiabetic nephropathiesmedicineChronic renal failureHumansDiabetic NephropathiesDiabetic kidney diseaseESRDSodium-Glucose Transporter 2 InhibitorsTransplantationbusiness.industryType 2 diabetesNefropaties diabètiquesmedicine.diseasePrognosisBlood pressureDiabetes Mellitus Type 2NephrologyHeart failureSodium/Glucose Cotransporter 2Insuficiència renal crònicabusinessSGLT2 inhibitorsKidney disease
researchProduct

Prediction of dilutional acidosis based on the revised classical dilution concept for bicarbonate

2004

Due to the controversy surrounding the term dilutional acidosis, the classical dilution concept for bicarbonate has been rigorously revised for the prediction of pH, actual bicarbonate concentration, and base excess. In the algorithms derived for buffer solutions, blood, and whole body (1-, 2-, and 3-fluid compartment), only bicarbonate is considered. On dilution at constant Pco2, the final concentration of bicarbonate is the sum in terms of pH, due to the following processes: dilution, formation from chemical reaction with the nonbicarbonate buffers phosphate, hemoglobin, and plasma proteins, and transfer from erythrocytes and interstitial fluid to plasma. At constant Pco2, the level of c…

medicine.medical_specialtyMetabolic Clearance RatePhysiologyBicarbonateVolume replacementIndicator Dilution TechniquesModels Biologicalchemistry.chemical_compoundPhysiology (medical)Volume expansionBicarbonate buffering systemmedicineAnimalsHumansComputer SimulationTissue DistributionDiagnosis Computer-AssistedAcidosisChemistryAcute normovolemic hemodilutionMetabolic disorderHydrogen-Ion ConcentrationPrognosismedicine.diseaseSurgeryDilutionBicarbonatesModels ChemicalAnesthesiamedicine.symptomAcidosisAlgorithmsJournal of Applied Physiology
researchProduct

Matrix metalloproteinase gene polymorphisms and oral cancer

2012

Since oral squamous cell carcinoma (OSCC) is the most prevalent malignant cancer in the oral cavity, several researches have been performed to study the role of important enzymes in this disease. Among them, the matrix metalloproteinases (MMPs) are highlighted, due to the fact that they are proteinases responsible to degrade many extra-cellular matrix components, making possible the invasion of neoplasic cells. Important tools in cancer prognosis have been utilized aiming to correlate high levels of MMPs and OSCC, such as immunohistochemical, zymographic and mRNA detection methods. However, these techniques are usually applied after cancer detection, characterizing a curative but not a prev…

medicine.medical_specialtyModern medicineOral Medicine and Pathologybusiness.industryCancerOdontologíaReviewDiseaseMatrix metalloproteinase:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseBioinformaticsCiencias de la saludCancer prognosisstomatognathic diseasesUNESCO::CIENCIAS MÉDICASmedicineImmunohistochemistrybusinessGeneral DentistryGenePreventive healthcare
researchProduct

Link of the mechanisms of action of glatiramer acetate to its long-term clinical data

2009

A consequence of the long-term nature of progression in multiple sclerosis is that treatment needs to be provided over the long term. Gathering evidence for long term clinical efficacy, safety and patient acceptance of immunomodulatory therapies is thus a critically important issue. However, pivotal trials, which generally last no more than two years, cannot address this issue. Glatiramer acetate is the only immunomodulatory treatment for which prospective data is available covering a treatment period of over a decade. In the long-term extension of the pivotal trial of glatiramer acetate, 108 patients have been followed for a mean treatment duration of 10.1 years. At the end of the treatmen…

medicine.medical_specialtyMultiple SclerosisTimeSecondary PreventionHumansMedicineClinical efficacyGlatiramer acetateIntensive care medicineClinical Trials as Topicbusiness.industryMultiple sclerosisGlatiramer AcetatePrognosismedicine.diseaseTreatment periodTerm (time)Clinical trialTreatment OutcomeNeurologyAmbulatoryDisease ProgressionPhysical therapyObservational studyNeurology (clinical)PeptidesbusinessRisk Reduction BehaviorImmunosuppressive Agentsmedicine.drugJournal of the Neurological Sciences
researchProduct

Monofocal hepatocellular carcinoma: How much does size matter?

2020

Background & Aims: According to the Barcelona Clinic Liver Cancer (BCLC) staging system, monofocal hepatocellular carcinoma (HCC) is classified as early (BCLC A) irrespective of its size, even though controversies still exist regarding staging and treatment of large tumours. We aimed at evaluating the appropriate staging and treatment for large (>5 cm) monofocal (HCC). Methods: From the Italian Liver Cancer database, we selected 924 patients with small early monofocal HCC (2-5 cm; SEM-HCC), 163 patients with larger tumours (>5 cm; LEM-HCC) and 1048 intermediate stage patients (BCLC B). Results: LEM-HCC patients had a worse overall survival (OS) than SEM-HCC (31.0 vs 49.0 months; P…

medicine.medical_specialtyMultivariate analysisCarcinoma HepatocellularIndependent predictorGastroenterologyResection03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalHepatectomyHumansStaging systemNeoplasm StagingRetrospective StudiesSettore MED/12 - GastroenterologiaHepatologytreatmentbusiness.industrySettore MED/09 - MEDICINA INTERNALiver Neoplasmsbclc staging systemmonofocal hepatocellular carcinomamedicine.diseasedigestive system diseasesSurvival benefitItaly030220 oncology & carcinogenesisHepatocellular carcinomabclc staging system; liver resection; monofocal hepatocellular carcinoma; prognosis; treatmentliver resection030211 gastroenterology & hepatologyprognosisbusinessLiver cancerprognosi
researchProduct